SonoSite Announces Remarkable New Patient Safety Results Achieved by Thomas Jefferson University Hospital

  SonoSite Announces Remarkable New Patient Safety Results Achieved by Thomas
  Jefferson University Hospital

    Introducing a New Care Path Strategy to Reduce Complications and Costs

  Ultrasound-Guided Peripheral IVs Replace High-Risk Central Venous Catheter
                      Line Placements in 84% of Patients

Business Wire

BOTHELL, Wash. -- November 08, 2012

FUJIFILM SonoSite, Inc., the world leader and specialist in bedside and
point-of-care ultrasound, announces new patient safety data achieved by Thomas
Jefferson University Hospitals, Inc. (TJUH), a 957-bed academic medical center
located in Philadelphia. Arthur Au, MD, a Clinical Instructor at Jefferson
Medical College and Emergency Medicine physician at TJUH presented new data
from an internal ultrasound-guidance study at the 2011 American College of
Emergency Physicians (ACEP) conference.

Discovering a New Care Path Strategy

The goal of the study at TJUH was to determine if the number of Central Venous
Catheter (CVC) placements could be reduced or replaced with a safer
alternative- ultrasound-guided peripheral intravenous (USGPIVs) in patients
with difficult IV access. The clinical challenge with most patients entering
the emergency department includes: obesity, edema, or small veins that are
difficult to visualize, making it incredibly difficult for a physician or
nurse to place a peripheral IV.

With more than 5 million CVCs lines placed in US hospitals per year, this is
one of the most common invasive procedures performed in the emergency
department^1. Unfortunately, CVC placements are risky procedures and are
typically performed by inserting a large catheter into one of the patient’s
major vessels: the jugular vein (neck), femoral vein (groin), or the
subclavian vein (chest). With the high-risk nature of the procedure, studies
show that CVCs have a complication rate of about 15%, patients are more
susceptible to acquiring a catheter-related blood stream infection and the
procedure can result in morbidity^2.

Results

The study was conducted in two urban emergency departments utilizing
SonoSite’s M-Turbo ultrasound systems and the results showed that 85% of the
time USGPIVs eliminated the need for the placement of CVCs in patients with
difficult IV access. Assuming the standard CVC complication rate of
approximately 15%, it was determined that in this group alone, the use of
USGPIVs would reduce complication rates to 2.25%, which would significantly
reduce healthcare costs in the emergency department.

“This data is pivotal for emergency medicine and the overall impact it can
have on patient safety and cost reductions in the hospital,” said Bon Ku, MD,
MPP, of the Department of Emergency Medicine at TJUH. “TJUH is a Level 1
trauma center and has made it standard practice in the emergency departments
that patients with difficult IV access undergo attempts at ultrasound-guided
peripheral IV catheter placement before inserting a central venous catheter."

The results were reported online ahead of print July 12, 2012 in the American
Journal of Emergency Medicine.

Preparation for New Medicare Regulations: Greater Attention to Cost Reductions

New data such as Jefferson’s and its potential for cost savings is
instrumental as new healthcare reform regulations go into effect, which will
undoubtedly impact a hospital’s bottom line. With the implementation of
Medicare’s Value-Based Purchasing Program (VBP), hospitals are required to
track and report quality measures and will also begin to monitor the cost of
each patient’s stay. For instance, complications such as an iatrogenic
pneumothorax (collapsed lung), can be a very expensive medical error with the
cost per incident ranging from $17,000 to $45,000, according to a study by the
Agency for Healthcare Quality and Research (AHRQ)^3. This will be a Patient
Safety Indicator under VBP in FY 2015 and will also figure into the cost
efficiency calculations. Jefferson’s data is the quintessential example of a
proactive health system that is improving healthcare delivery and preparing
hospitals for the future of healthcare reform.

About  FUJIFILM SonoSite, Inc.

SonoSite, Inc. (www.sonosite.com), a subsidiary of FUJIFILM Corporation, is
the innovator and world leader in bedside and point-of-care ultrasound and an
industry leader in ultra high-frequency micro-ultrasound technology and
impedance cardiography equipment. Headquartered near Seattle, the company is
represented by ten subsidiaries and a global distribution network in over 100
countries. SonoSite's small, lightweight systems are expanding the use of
ultrasound across the clinical spectrum by cost-effectively bringing
high-performance ultrasound to the point of patient care.

^1 Feller-Klopman, D, “Ultrasound-Guided Internal Jugular Access,” Chest,
July, 2007: http://chestjournal.chestpubs.org/content/132/1/302.full

^2 Feller-Klopman, D, “Ultrasound-Guided Internal Jugular Access,” Chest,
July, 2007: http://chestjournal.chestpubs.org/content/132/1/302.full

^3 Zhan C, M Smith, and D Stryer. Incidences, Outcomes and Factors Associated
with Iatrogenic Pneumothorax in Hospitalized Patients [abstract]. In: Academy
Health Annual Research Meeting.; 2004; San Diego, Calif. Academy Health. 2004;
21: abstract no. 1862.
http://www.academyhealth.org/files/2004/abstracts/quality.pdf

Contact:

SonoSite, Inc.
Lisa Fritzky, 425-951-1375